Evaluation of endometrial thickness in hormone receptor positive early stage breast cancer postmenopausal women switching from adjuvant tamoxifen treatment to anastrozole

Tamoxifen Treatment ◽

Adjuvant Tamoxifen ◽

Cost-Effectiveness of Letrozole Versus Tamoxifen as Initial Adjuvant Therapy in Hormone Receptor–Positive Postmenopausal Women with Early-Stage Breast Cancer

Clinical Breast Cancer ◽

10.3816/cbc.2007.n.018 ◽

2007 ◽

Vol 7 (8) ◽

pp. 608-618 ◽

Cited By ~ 19

Author(s):

Thomas E. Delea ◽

Jon Karnon ◽

Oleg Sofrygin ◽

Simu K. Thomas ◽

Natalie L. Papo ◽

...

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Adjuvant Therapy ◽

Postmenopausal Women ◽

Hormone Receptor ◽

Early Stage ◽

Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype

Annals of Oncology ◽

10.1093/annonc/mdv215 ◽

2015 ◽

Vol 26 (8) ◽

pp. 1685-1691 ◽

Cited By ~ 49

Author(s):

M. Gnant ◽

I. Sestak ◽

M. Filipits ◽

M. Dowsett ◽

M. Balic ◽

...

Keyword(s):

Breast Cancer ◽

Postmenopausal Women ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Early Stage ◽

Recurrence Score ◽

Intrinsic Subtype ◽

Combined Analysis ◽

Cost-effectiveness of letrozole (LET) versus anastrozole (ANA) in postmenopausal women (PMW) with hormone receptor-positive (HR+) early-stage breast cancer (EBC) based on indirect comparison of BIG 1-98 and ATAC.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e11013 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e11013-e11013 ◽

Cited By ~ 1

Author(s):

T. E. Delea ◽

M. A. Lipsitz ◽

S. C. Zelt ◽

A. Guo

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Postmenopausal Women ◽

Hormone Receptor ◽

Early Stage ◽

Indirect Comparison ◽

Faculty Opinions recommendation of Lumpectomy Plus Hormone or Radiation Therapy Alone for Women Aged 70 Years or Older With Hormone Receptor-Positive Early Stage Breast Cancer in the Modern Era: An Analysis of the National Cancer Database.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.736343660.793574002 ◽

2020 ◽

Author(s):

Lorenzo Livi ◽

Isacco Desideri

Keyword(s):

Breast Cancer ◽

Radiation Therapy ◽

Hormone Receptor ◽

Early Stage ◽

National Cancer Database ◽

Modern Era

Information needs of post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapy

Patient Education and Counseling ◽

10.1016/j.pec.2013.03.019 ◽

2013 ◽

Vol 93 (1) ◽

pp. 114-121 ◽

Cited By ~ 5

Author(s):

Deb Feldman-Stewart ◽

Yolanda Madarnas ◽

Mihaela Mates ◽

Christine Tong ◽

Eva Grunfeld ◽

...

Keyword(s):

Breast Cancer ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Information Needs ◽

Early Stage ◽

Adjuvant Endocrine Therapy ◽

Menopausal Women ◽

Post Menopausal

Efficacy of neratinib in hormone receptor-positive (HR+) patients who initiated treatment within 1 year of completing trastuzumab-based adjuvant therapy in HER2+ early-stage breast cancer (BC): subgroup analyses from the phase III ExteNET trial

The Breast ◽

10.1016/s0960-9776(19)30112-2 ◽

2019 ◽

Vol 44 ◽

pp. S18-S19

Author(s):

B. Ejlertsen ◽

F.A. Holmes ◽

S.K.L. Chia ◽

H. Iwata ◽

B. Moy ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Therapy ◽

Hormone Receptor ◽

Early Stage ◽

Phase Iii ◽

Subgroup Analyses

Factors Determining Anthracycline Use in Hormone Receptor Positive, Early-Stage Breast Cancer

Clinical Breast Cancer ◽

10.1016/j.clbc.2019.01.012 ◽

2019 ◽

Vol 19 (3) ◽

pp. e475-e480

Author(s):

Jordan Henderson ◽

Paul Adams ◽

Kimberly Barber

Keyword(s):

Breast Cancer ◽

Hormone Receptor ◽

Early Stage ◽

Adjuvant Tamoxifen Treatment Outcome According to Cytochrome P450 2D6 (CYP2D6) Phenotype in Early Stage Breast Cancer: Findings from the International Tamoxifen Pharmacogenomics Consortium.

10.1158/0008-5472.sabcs-09-33 ◽

2009 ◽

Cited By ~ 14

Author(s):

M. Goetz ◽

D. Berry ◽

T. Klein ◽

Keyword(s):

Breast Cancer ◽

Cytochrome P450 ◽

Treatment Outcome ◽

Early Stage ◽

Tamoxifen Treatment ◽

Adjuvant Tamoxifen ◽

Cytochrome P450 2D6 ◽

Cyp2d6 Phenotype ◽

P450 2D6

PCN216 ADJUVANT CHEMOTHERAPY GUIDED BY A 21-GENE EXPRESSION ASSAY IN HORMONE-RECEPTOR POSITIVE EARLY-STAGE BREAST CANCER: USE OF SIMULATION MODELING TO EXTEND AND TRANSLATE CLINICAL TRIAL RESULTS INTO PRACTICE

Value in Health ◽

10.1016/j.jval.2019.04.338 ◽

2019 ◽

Vol 22 ◽

pp. S96-S97

Author(s):

J. Jayasekera ◽

J. Mandelblatt ◽

S. O'Neill ◽

C. Schechter

Keyword(s):

Breast Cancer ◽

Gene Expression ◽

Clinical Trial ◽

Adjuvant Chemotherapy ◽

Hormone Receptor ◽

Simulation Modeling ◽

Early Stage ◽

Clinical Trial Results

Lumpectomy Plus Hormone or Radiation Therapy Alone for Women Aged 70 Years or Older With Hormone Receptor–Positive Early Stage Breast Cancer in the Modern Era: An Analysis of the National Cancer Database

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2019.07.052 ◽

2019 ◽

Vol 105 (4) ◽

pp. 795-802 ◽

Cited By ~ 15

Author(s):

Samantha M. Buszek ◽

Heather Y. Lin ◽

Isabelle Bedrosian ◽

Nina Tamirisa ◽

Gildy V. Babiera ◽

...

Keyword(s):

Breast Cancer ◽

Radiation Therapy ◽

Hormone Receptor ◽

Early Stage ◽

National Cancer Database ◽

Modern Era